Oramed Pharmaceuticals
ORMP
#8770
Rank
C$0.13 B
Marketcap
$3.32
Share price
3.02%
Change (1 day)
24.61%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): C$33.97 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of C$9.9 Million, an increase over its 2022 earnings that were of -C$50.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$33.97 M243.09%
2023 C$9.9 M-119.45%
2022 -C$50.92 Million39.17%
2021 -C$36.59 Million73.93%
2020 -C$21.04 Million18.53%
2019 -C$17.75 Million-16.62%
2018 -C$21.29 Million38.32%
2017 -C$15.39 Million12.51%
2016 -C$13.68 Million25.01%
2015 -C$10.94 Million18.18%
2014 -C$9.26 Million39.72%
2013 -C$6.63 Million46.4%
2012 -C$4.53 Million128.32%
2011 -C$1.99 Million-51.47%
2010 -C$4.09 Million35.21%
2009 -C$3.03 Million
2007 -C$4.75 Million607.04%
2006 -C$0.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.73 Billion-2,157.69%๐Ÿ‡บ๐Ÿ‡ธ USA
C$23.42 B 66,581.97%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
C$10.29 B 29,210.12%๐Ÿ‡ซ๐Ÿ‡ท France
-C$0.71 Million-102.01%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-C$0.29 Billion-899.66%๐Ÿ‡บ๐Ÿ‡ธ USA